Enhanced VAccines DEsign against antimicrobial REsistance

MSCA (Marie Skłodowska-Curie)HORIZON-TMA-MSCA-DNID: 101223893
EC Contribution
€45,527
Consortium Size
23 orgs
Start Year
2026
Summary

EVADERE (Enhanced VAccines DEsign against antimicrobial REsistance) is a multidisciplinary consortium of 14 interna-tionally recognised experts (12 from academia and 2 from industry) from 9 European countries who will provide 15 doctor-al candidates (DCs) with high-quality inter-sectoral training in discovery and development of vaccines targeting antimicro-bial resistance (AMR) based on innovative antigens, adjuvants, and delivery methods. Trainees will acquire a broad range of transferable skills to underpin their resilience for future careers in vaccine research within academia and industry respecting gender and equality.

Consortium (23)